Craig Hallum Raises KORU Medical Systems (NASDAQ:KRMD) Price Target to $6.00

KORU Medical Systems (NASDAQ:KRMD - Free Report) had its price objective raised by Craig Hallum from $5.00 to $6.00 in a report published on Friday,Benzinga reports. They currently have a buy rating on the stock.

Other research analysts also recently issued research reports about the stock. Lake Street Capital lifted their target price on shares of KORU Medical Systems from $4.00 to $5.00 and gave the stock a "buy" rating in a report on Tuesday. Piper Sandler lifted their price objective on KORU Medical Systems from $3.00 to $3.50 and gave the stock an "overweight" rating in a research note on Thursday, November 14th. Finally, Canaccord Genuity Group increased their target price on KORU Medical Systems from $3.00 to $4.00 and gave the company a "buy" rating in a research note on Thursday, November 14th. Four analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, KORU Medical Systems presently has an average rating of "Buy" and an average target price of $4.50.

KORU Medical Systems Stock Up 2.3 %

Shares of KRMD traded up $0.09 during mid-day trading on Friday, hitting $4.09. 192,961 shares of the company's stock were exchanged, compared to its average volume of 88,187. The stock has a market cap of $187.49 million, a price-to-earnings ratio of -16.36 and a beta of 0.45. The firm has a fifty day moving average of $3.82 and a two-hundred day moving average of $2.97. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01. KORU Medical Systems has a twelve month low of $1.98 and a twelve month high of $4.60.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Meros Investment Management LP boosted its position in KORU Medical Systems by 20.7% in the 2nd quarter. Meros Investment Management LP now owns 804,380 shares of the company's stock valued at $2,132,000 after buying an additional 137,918 shares during the last quarter. Empire Financial Management Company LLC acquired a new position in shares of KORU Medical Systems during the third quarter valued at $259,000. Point72 Asia Singapore Pte. Ltd. bought a new position in KORU Medical Systems in the second quarter valued at about $107,000. Geode Capital Management LLC increased its position in KORU Medical Systems by 6.5% in the third quarter. Geode Capital Management LLC now owns 462,128 shares of the company's stock worth $1,262,000 after purchasing an additional 28,323 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its position in KORU Medical Systems by 77.7% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company's stock valued at $168,000 after purchasing an additional 26,860 shares during the period. Institutional investors and hedge funds own 58.60% of the company's stock.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.